Fulgent Genetics, Inc.
FLGT
$18.82
-$0.74-3.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 292.45M | 283.47M | 277.76M | 290.71M | 287.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 292.45M | 283.47M | 277.76M | 290.71M | 287.53M |
| Cost of Revenue | 178.99M | 176.26M | 177.17M | 177.04M | 179.78M |
| Gross Profit | 113.46M | 107.22M | 100.60M | 113.67M | 107.75M |
| SG&A Expenses | 127.63M | 124.35M | 132.68M | 130.26M | 129.06M |
| Depreciation & Amortization | 7.97M | 7.97M | 7.93M | 7.90M | 7.87M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 364.36M | 357.39M | 366.43M | 362.08M | 359.80M |
| Operating Income | -71.92M | -73.92M | -88.67M | -71.38M | -72.27M |
| Income Before Tax | -49.51M | -51.96M | -189.12M | -163.72M | -167.21M |
| Income Tax Expenses | -7.64M | -8.14M | -17.15M | 7.01M | 6.03M |
| Earnings from Continuing Operations | -41.87 | -43.82 | -171.96 | -170.74 | -173.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.10M | 1.11M | 7.00M | 7.31M | 7.29M |
| Net Income | -40.78M | -42.71M | -164.97M | -163.43M | -165.95M |
| EBIT | -71.92M | -73.92M | -88.67M | -71.38M | -72.27M |
| EBITDA | -47.73M | -48.99M | -63.40M | -45.61M | -46.34M |
| EPS Basic | -1.34 | -1.42 | -5.53 | -5.48 | -5.57 |
| Normalized Basic EPS | -0.77 | -0.83 | -0.99 | -0.67 | -0.74 |
| EPS Diluted | -1.34 | -1.42 | -5.53 | -5.49 | -5.58 |
| Normalized Diluted EPS | -0.77 | -0.83 | -0.99 | -0.67 | -0.74 |
| Average Basic Shares Outstanding | 122.00M | 120.94M | 120.05M | 119.65M | 119.37M |
| Average Diluted Shares Outstanding | 122.00M | 120.94M | 120.05M | 119.65M | 119.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |